Lars Iversen, Merle Kurvits, Anja Marieke Snel-Prentø, & Alan Menter. (2020). Calcipotriol/Betamethasone Dipropionate Cutaneous Foam Treatment for Psoriasis in Patients With BSA 5-15% and PGA ≥ 3: Post-Hoc Analysis From Three Randomized Controlled Trials. Adis, Springer Healthcare.
Chicago Style (17th ed.) CitationLars Iversen, Merle Kurvits, Anja Marieke Snel-Prentø, and Alan Menter. Calcipotriol/Betamethasone Dipropionate Cutaneous Foam Treatment for Psoriasis in Patients With BSA 5-15% and PGA ≥ 3: Post-Hoc Analysis From Three Randomized Controlled Trials. Adis, Springer Healthcare, 2020.
MLA (9th ed.) CitationLars Iversen, et al. Calcipotriol/Betamethasone Dipropionate Cutaneous Foam Treatment for Psoriasis in Patients With BSA 5-15% and PGA ≥ 3: Post-Hoc Analysis From Three Randomized Controlled Trials. Adis, Springer Healthcare, 2020.